Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A , B Fluorescence polarisation analysis of binding affinities between BRCA1-BRCT domain and RIF1-L phospho-peptide with indicated treatment or mutations. Source data are provided as a file. C Crystal structure of RIF1-L phospho-peptide (stick presentation) in complex with BRCA1-BRCT domain (space-filling presentation), solved by X-ray diffraction. The phosphorus atom is represented in orange. Residues on RIF1-L phospho-peptide are labelled with pink text (S2265, K2267, F2268, K2269). Residue on BRCA-BRCT domain is labelled with green text (E1698). D Model of RIF1-L interaction with BRCA1. In RIF1-L protein presentation, purple bards indicate PP1-interacting motifs; pink box indicates Exon 31; red bar indicates the S 2265 PKF motif. RIF1-L phosphoS 2265 PKF motif binds to the C-terminal tandem BRCT domains of BRCA1.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Fluorescence, Binding Assay, Residue

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A Representative images of RIF1-BRCA1 PLA foci in RPE-1 cells with indicated treatments. Scalebar: 10 µm. B Quantification of RIF1-BRCA1 PLA foci number per nucleus in cells from the experiment as ( A ). p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons using the ‘unt’ sample as the control group. C RIF1-BRCA1 PLA analysis in RPE-1 cells with indicated treatments. HU: 4 mM 24 h; APH: 4 µM 24 h; CPT: 100 nM 24 h. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons using the ‘unt’ sample as the control group. D Schematic representation of RIF1-L Morpholinos (bright blue lines) targeting the splicing signals for RIF1-L Exon31 inclusion. The RIF1-L morpholinos were designed to inhibit spliceosome recruitment leading to the skipping of Exon 31 during pre-mRNA splicing. Treatment with RIF1-L Morpholinos is expected to prevent the generation of RIF1-L mRNA. E Gel analysis of RT-PCR-based analysis to distinguish RIF1-L and RIF1-S transcripts in Control and RIF1-L Morpholino-treated RPE-1 cells. The upper band corresponds to RIF1-L mRNA and the lower band corresponds to RIF1-S mRNA. Experimental procedure described in Supplementary Fig. . F Western blot analysis of total RIF1 protein expression in Control and RIF1-L Morpholino-treated RPE-1 cells. Mo: abbreviation for Morpholino. G RIF1-BRCA1 PLA analysis in Control and RIF1-L Morpholino-treated RPE-1 cells with indicated HU treatments. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups. In the Tukey box-and-whisker plots of this and the following figures, box represents 1st to 3rd quartile of data points. Horizontal line inside the box represents median. Whisker extending from box represent 1.5x interquartile range. Individual dots represent outliers greater than the value at whisker bound. n numbers of samples are listed in Supplementary Data . Numbers of independent experimental repeats is stated in ‘Statistics and Reproducibility’ section. Source data are provided as a file.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Control, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Whisker Assay

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A Western blot analysis of 53BP1 depletion by siRNA in RPE-1 cells. B RIF1-BRCA1 PLA analysis in Control or 53BP1-depleted RPE-1 cells with indicated treatments. HU: 4 mM 24 h. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups. C Experiment procedure to label S phase cells with EdU, followed by RIF1-BRCA1 PLA analysis. An asynchronous RPE-1 cell culture was pulse labelled with EdU for 15 min, and then treated with no or 4 mM HU for 4 h. Cells were fixed at the end of HU treatment and subjected to RIF1-BRCA1 PLA procedures. D Left: representative images acquired from the experiment described in ( C ). unt: not treated with HU; HU: 4 mM 4 h. Scalebar: 10 µm. Right: quantification of RIF1-BRCA1 PLA foci per nucleus. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups. E RIF1-BRCA1 PLA analysis in RPE-1 cells collected at indicated timepoints after removal of HU. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups. F RIF1-BRCA1 PLA analysis in RPE-1 cells following indicated kinase inhibitor and HU treatments. HU: 4 mM 24 h; ATRi (VE-821): 1 µM 24 h; Chk1i (PF-477736): 1 µM 24 h. p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Western Blot, Control, Cell Culture

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A , B RIF1-BRCA1 co-IP analysis. Flp-In T-REx 293 cells expressing indicated GFP-RIF1 constructs were transfected with FLAG-BRCA1 plasmid. FLAG IP was performed and immunoblotted for GFP-RIF1 and FLAG-BRCA1. C RIF1-BRCA1 co-IP analysis. Reciprocal co-IP to ( A , B ). Flp-In T-REx 293 cells expressing indicated GFP-RIF1 constructs were transfected with FLAG-BRCA1 plasmid. GFP IP was performed and immunoblotted for GFP-RIF1 and FLAG-BRCA1. D RIF1-BRCA1-BRCT co-IP analysis. Flp-In T-REx 293 cells expressing indicated GFP-RIF1 constructs were transfected with mCherry-BRCA1-BRCT plasmid. mCherry IP was performed and immunoblotted for GFP-RIF1 (top panels). Lower panels show protein visualised by stain-free gel imaging. E Schematic representation of RIF1 constructs used in ( D ) and their co-IP analysis outcomes with BRCA1-BRCT. F Western blot analysis of RIF1-L-Phospho-S2265 signal in HeLa RIF1 KO cells supplemented with Dox-inducible RIF1-L or RIF1-L-pp1bs. (HeLa cell characterisation presented in Supplementary Fig. ). G Representative images of RIF1-BRCA1 PLA foci in HeLa RIF1 KO cells (left) and in RIF1 KO cells supplemented with RIF1-L (middle) or RIF1-L-pp1bs (right). HU: 4 mM 24 h. Scalebar: 10 µm. H Quantification of RIF1-BRCA1 PLA foci number per nucleus in cells from the experiment as ( G ). p values calculated by Kruskal-Wallis test with Dunn’s multiple comparisons between indicated groups. I RIF1-BRCA1-BRCT co-IP analysis. Flp-In T-REx 293 cells expressing GFP-RIF1-L-pp1bs or GFP-RIF1-L were transfected with mCherry-BRCA1-BRCT plasmid. 16 h after transfection, cells were further treated with no, or 4 h, or 24 h of 4 mM HU. mCherry IP was performed and immunoblotted for GFP-RIF1 (top panels). Lower panels show protein visualised by stain-free gel imaging.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Co-Immunoprecipitation Assay, Expressing, Construct, Transfection, Plasmid Preparation, Staining, Imaging, Western Blot

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A Representative images of GFP-RIF1-L or GFP-RIF1-L-pp1bs signal in HeLa cells, with indicated treatments. unt: not treated with HU; HU: 4 mM, 24 h. Scalebar: 10 µm. B Quantification of GFP-RIF1-L or GFP-RIF1-L-pp1bs foci in cells from the experiment as ( A ). Means and standard errors of three independent experiments are plotted. p values (two-tailed) calculated by Student’s t test. C Left: Representative images of GFP-RIF1 fluorescence and BRCA1 immunofluorescence in HeLa RIF1 KO, +GFP-RIF1-L and +GFP-RIF1-L-pp1bs cells. All samples were treated with 4 mM 24 h HU. Scalebar: 10 µm. Right: BRCA1 nuclear signal intensity fold change. Median intensity values from three independent experiments were recorded (see Supplementary Fig. for one representative experiment). Fold changes were determined by normalising to values of the RIF1 KO sample. Means and standard errors were shown. p values (two-tailed) calculated by one-sample t test. Source data are provided as a file. D Left: Representative images of BRCA1 immunofluorescence in HeLa cells treated with siCtrl or siRIF1. All samples were treated with 4 mM 24 h HU. Scalebar: 10 µm. Right: BRCA1 nuclear signal intensity fold change (normalised to siCtrl cells). Data plotted as described in ( C ). p values (two-tailed) calculated by one-sample t test. E An example of co-localisation between GFP-RIF1-L-pp1bs, BRCA1 and γH2AX in HeLa cells. This sample was treated with 4 mM 24 h HU. BRCA1 and γH2AX signals were generated by immunostaining. Scalebar: 5 µm. F Quantification of co-localisation between GFP-RIF1-L-pp1bs, BRCA1 and γH2AX in cells from the experiment as ( E ). Means and standard errors of four independent experiments are plotted. G An example of co-localisation between GFP-RIF1-L-pp1bs, BRCA1 and RAD51 in HeLa cells. This sample was treated with 4 mM 24 h HU. BRCA1 and RAD51 signals were generated by immunostaining. Scalebar: 5 µm. H Quantification of co-localisation between GFP-RIF1-L-pp1bs, BRCA1 and RAD51 in cells from the experiment as ( G ). Means and standard errors of three independent experiments are plotted.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Two Tailed Test, Fluorescence, Immunofluorescence, Generated, Immunostaining

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A Representative images of RAD51 immunofluorescence in HeLa cells that are RIF1 KO, or express indicated RIF1 constructs. Nuclei outlines are drawn in white. RAD51 signal is shown in orange. unt: not treated with HU; HU: 4 mM 24 h. Scalebar: 10 µm. B Percentage of nuclei containing indicated number of RAD51 foci in cells from the experiment as ( A ). Means and standard errors of three independent experiments are plotted. p values calculated by chi-square tests. Source data are provided as a Source Data file. C Western blot analysis of BRCA1 depletion by siRNA in HeLa cells. D Representative images of RAD51 immunofluorescence in HeLa cells with indicated RIF1 expression and siRNA treatments. All samples were treated with 4 mM 24 h HU. Scalebar: 10 µm. E Percentage of nuclei containing indicated number of RAD51 foci in cells from the experiment as ( D ). Means and standard errors of two independent experiments are plotted. p values calculated by chi-square tests. Source data are provided as a file. F Schematic diagram of the reporter construct in HCT116 HR reporter cell lines to assess homologous recombination-mediated repair at Cas9n-induced broken forks. G Flow cytometry analysis of HR-mediated fork repair assessed by the reporter shown in ( F ), in HCT116 HR reporter cells expressing indicated RIF1 derivatives made at the endogenous RIF1 loci by CRISPR modification. (See Supplementary Fig. for HCT116 HR reporter cell characterisation). Dots of the same colour represent data collected from the same experiment. Means and standard errors of three independent experiments are plotted. p values (two-tailed) calculated by paired Student’s t test. H Number of micronuclei per 100 cells in HeLa cells with indicated RIF1 expression and treatments. unt: not treated with HU; HU: 4 mM 24 h. Means and standard errors of three independent experiments are plotted. p values (one-tailed) calculated by paired Student’s t test.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Immunofluorescence, Construct, Western Blot, Expressing, Homologous Recombination, Flow Cytometry, CRISPR, Modification, Two Tailed Test, One-tailed Test

Journal: Nature Communications

Article Title: The human RIF1-Long isoform interacts with BRCA1 to promote recombinational fork repair under DNA replication stress

doi: 10.1038/s41467-025-60817-y

Figure Lengend Snippet: A Model of how RIF1-L promotes recovery from replication stress. ( i ) Replication fork progresses in unperturbed condition. ( ii ) Replication fork stalls upon replication stress. RIF1 and BRCA1 are independently recruited to stalled forks. ( iii ) Persistent stalling leads to fork breakage and subsequent formation of a single-ended DSB. RIF1-L interacts with BRCA1 dependent on phosphorylation of RIF-L S 2265 . RAD51 localises to broken forks. ( iv ) RIF1-L-BRCA1 complex facilitates the loading of RAD51 onto seDSBs. RAD51 nucleofilament thereby initiate strand invasion into the sister chromatid and proceed to homology-directed repair. B A speculative model proposing that RIF1-L may bridge the broken daughter and parental DNAs. Unmethylated H4K20 is enriched on newly-replicated nascent chromatin (pale orange octagons), enabling BRCA1-BARD1 recruitment. Di-methylated H4K20 is enriched on un-replicated parental chromatin (grey octagons), favouring 53BP1. We speculate that RIF1-L may bind BRCA1 via its C-terminal phosphorylated SPKF motif, while interacting with 53BP1 via its N-terminal residues. In this manner, RIF1-L may facilitate the homology pairing between sister chromatids. In the RIF1-L protein, pale blue curve represents the IDR region; red bar represents the S 2265 PKF motif. ‘N’ and ‘C’ marks N-terminal and C-terminal of the RIF1-L protein.

Article Snippet: The FLAG-BRCA1 plasmid was obtained from Addgene (#52504, pDEST 3x Flag-pcDNA5-FRT/TO-BRCA1 ).

Techniques: Phospho-proteomics, Methylation

Journal: Molecular Cell

Article Title: An Adversarial DNA N 6 -Methyladenine-Sensor Network Preserves Polycomb Silencing

doi: 10.1016/j.molcel.2019.03.018

Figure Lengend Snippet:

Article Snippet: Plasmid: pCMV6-XL4 ASXL1 (p.Y591X) 3x Flag , , Addgene plasmid 74261.

Techniques: Luciferase, Recombinant, SYBR Green Assay, Sequencing, Methylated DNA Immunoprecipitation, RNA Sequencing Assay, Plasmid Preparation, CRISPR, Software

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: (A) Schematic representing domain structure of ASXL1. Indicated on ASXL1 is the proposed BRD4 binding site (538-578; dark red) and the relative positions of commonly mutated residues in cancer that produce a truncated protein either by frameshift (black circle) or nonsense (grey circle). (B) Multiple sequence alignment of the BRD4 binding motif in ASXL1 compared with known BRD4-ET interactors, highlighting a conserved five residue motif. These residues we propose bind BRD4 in the same groove of the BRD4-ET as known interactors (PDB: 6BGG; ET bound by CHD4) (C/D) Coomassie-stained gels showing pulldown of His 6 BRD4 600-678 by GST-ASXL1 537-587 (C), and the reciprocal pulldown; His 6 MBP-ASXL1 537-587 by GST-BRD4 600-678 (D).

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Binding Assay, Sequencing, Residue, Staining

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: (A) Isothermal titration calorimetry of ASXL1 and BRD4-ET. Isothermal titration calorimetry (ITC) of His 6 MBP-fused ASXL1 537-587 injected into BRD4-ET domain reveals a high affinity interaction, with K D 0.535 μM. Data points of triplicate titrations, following His 6 MBP titration subtraction. (B) Introduction of point mutations within the binding sequence of ASXL1 disrupts binding of His 6 MBP-ASXL1 537-587 to GST-BRD4 600-678 . Coomassie-stained gels showing pulldown of His 6 MBP-ASXL1 537-587 by GST-BRD4 600-678 . Multiple sequence alignment of the ASXL1 mutations below; the residues colored according to ALSCRIPT Calcons. (C) Model of ASXL1 binding to BRD4-ET (purple) based on PDB: 2NCZ; indicating the five residues of the core motif.

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Isothermal Titration Calorimetry, Injection, Titration, Binding Assay, Sequencing, Staining

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: Analytical size exclusion chromatography (SEC) of His 6 -ASXL1 567-587 -Lysozyme (Red) and His 6 BRD4 600-678 (Pink), showing complex formation (Purple).

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Size-exclusion Chromatography

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: Coomassie-stained gels showing pulldown of N-terminal (A) and C-terminal truncations (B) of His 6 MBP-ASXL1 by GST-BRD4-ET. Coomassie-stained gels to show relative expression of input His 6 MBP-ASXL1 constructs. (C) Isothermal titration calorimetry of ASXL1 and BRD4-ET. Isothermal titration calorimetry (ITC) of shorter His 6 MBP-fused ASXL1 567-587 injected into BRD4-ET domain reveals a high affinity interaction, with K D = 1.36 μM. Data points of triplicate titrations, following His 6 MBP titration subtraction. (D) BRD4-ET bound to MLV(2N3K) and NSD3 (2NCZ).

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Staining, Expressing, Construct, Isothermal Titration Calorimetry, Injection, Titration

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: (A) ASXL1 binds to the highly conserved ET domain of BRD2, BRD3 and BRD4. Coomassie-stained gels showing pulldown of His 6 MBP-ASXL1 537-587 by GST-BRD2 632-710 , GST-BRD3 562-640 and GST-BRD4 600-678 . (B) Multiple sequence alignment of ASXL1, ASXL2 and ASXL3; the residues colored according to ALSCRIPT Calcons, demonstrates the conservation of the binding site; the core motif is highlighted (red box). (C) BRD4 binds ASXL1, ASXL2 and ASXL3. Coomassie-stained gels showing pulldown of His 6 MBP-ASXL1 537-587 , His 6 MBP-ASXL2 582-634 and His 6 MBP-ASXL3 977-1027 by GST-BRD4 600-678 . (D) Isothermal titration calorimetry of ASXL1 (green), ASXL2 (red) and ASXL3 (blue) injected into BRD4-ET domain reveals all ASXL homologues tightly bind the BRD4-ET domain. Data points of triplicate titrations, following His 6 MBP titration subtraction.

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Staining, Sequencing, Binding Assay, Isothermal Titration Calorimetry, Injection, Titration

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: (A) Schematic showing the approach used for targeted analysis. TurboID was fused to BRD4-ET and used to investigate the interaction with different lengths of ASXL1 (B) Proximity based labelling assays indicate that BRD4 interacts with ASXL1 Y591X and neither the full-length, nor ASXL1 1-472 which lacks the ET binding site. HEK293T cells were transiently co-transfected with either TurboID-BRD4 or TurboID alone and varying lengths of ASXL1. Cells were treated with biotin for ten minutes prior to lysis. Immunoprecipitation and Western blotting were performed using to determine if ASXL1 was biotinylated. (C) Quantification of ASXL1 enrichment using parallel reaction-monitoring (PRM) mass spectrometry with isotopically-labelled peptide to determine fold enrichment of ASXL1 after one hour treatment with biotin and immunoprecipitation. (D) Representative ion intensities of the strongest y-ion (y6) of the GQAEVTQDPAPLLR peptide in overlaid spectra of the endogenous peptide (blue trace) and heavy stable isotope labelled internal standard peptide (red trace).

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Binding Assay, Transfection, Lysis, Immunoprecipitation, Western Blot, Targeted Proteomics, Mass Spectrometry

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: Quantification of ASXL1 enrichment using parallel reaction-monitoring (PRM) mass spectrometry with isotopically-labelled peptide to determine fold enrichment of ASXL1 after one hour treatment with biotin and immunoprecipitation (A) Quantification using the second ASXL1 peptide (IQAEPDNLAR) (B) f mol of ASXL1 detected and CV % for IQAEPDNLAR (C) f mol of ASXL1 detected and CV % for GQAEVTQDPAPLLR, peptide analysis .

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Targeted Proteomics, Mass Spectrometry, Immunoprecipitation

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: Protein identification following streptavidin enrichment of cells treated with TurboID-BRD4 alone or TurboID-BRD4 with either Full-length ASXL1 or ASXL1 Y591X . A volcano plot was generated to demonstrate changes between proteins detected with FL ASXL1 (A) or ASXL1 Y591X (B) compared with the control (BRD4 alone). The fold-change (ASXL1/BRD4 alone) is plotted against the statistical significance (-log10p-value). Horizontal dashed line indicates where p = 0.05/ Proteins with significant p-values are highlighted (red) and labelled. (C) Comparative plot of FL ASXL1 and ASXL1 Y591X . The fold-change (ASXL1 FL/BRD4 alone) is plotted against the fold-change (ASXL1 Y591X /BRD4 alone). Proteins which are significantly changed in either data set are highlighted (red).

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: Generated, Control

Journal: bioRxiv

Article Title: Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding

doi: 10.1101/2021.07.15.452438

Figure Lengend Snippet: The fold-change (ASXL1 FL/BRD4 alone) is plotted against the fold-change (ASXL1 Y591X /BRD4 alone) to determine any difference in profile. Proteins which are known BRD4-ET interactors and PR-DUB proteins are highlighted in blue. The log2FC of each FL ASXL1 (B) and ASXL1 Y591X (C) (against BRD4-ET alone) was plotted against the crap_score. Proteins with significant p-values are highlighted (red). Proteins of interest are those which have a low crap_score but are significantly changed (highlighted in red)

Article Snippet: ASXL1 truncations were purchased from Addgene: pCMV6-XL4 ASXL1 (1-1304) (Addgene # 74244); pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAG (Addgene # 74261); pCMV6-XL4 ASXL1 (1-479) 3x FLAG (Addgene # 74262) were a gift from Anjana Rao.

Techniques: